Endece

Endece is a privately held biopharmaceutical company at the forefront of new discoveries and development. The company's proprietary compound library, invented and owned by ENDECE, aims to halt diseases by modulating specific biological pathways, thereby stimulating biological responses to restore function. The diseases the company focuses on have limited or no treatment options, with causes that may be unknown and clinical development paths that remain unclear, including multiple sclerosis (MS) and Alzheimer's disease.